Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 38, Issue 2, 2012, Pages 260-269

  Gould, Georgianna G ^a   Seillier, Alexandre ^a   Weiss, Gabriela ^a   Giuffrida, Andrea ^a   Burke, Teresa F ^a   Hensler, Julie G ^a   Rock, Crystal ^a   Tristan, Amanda ^a   McMahon, Lance R ^a   Salazar, Alexander ^a   O'Connor, Jason C ^a   Satsangi, Neera ^c   Satsangi, Rajiv K ^c   Gu, Ting Ting ^a   Treat, Keenan ^a   Smolik, Corey ^a,d   Schultz, Stephen T ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Rann Research Corporation   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Anandamide; Autoradiography; CB1 receptors; Marble burying; Paracetamol; Social interaction

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOPHENOL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NOLADIN ETHER; PARACETAMOL; SEROTONIN 1A RECEPTOR;

129S1 MOUSE; ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BTBR MOUSE; C57BL 6 MOUSE; CINGULATE GYRUS; COMPULSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INBRED STRAIN; KNOCKOUT MOUSE; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; RECEPTOR DENSITY; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STRAIN DIFFERENCE; WILD TYPE;

ACETAMINOPHEN; ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BENZOXAZINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; FRONTAL LOBE; GLYCERIDES; MALE; MICE; MICE, INBRED STRAINS; MORPHOLINES; NAPHTHALENES; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SEROTONIN; SOCIAL BEHAVIOR;

EID: 84862861825     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.04.011     Document Type: Article

References (65)

1. 2 receptor ligand specificity and the development of CB2-selective agonists. Curr Med Chem 2008, 15:1428-1443.
2. 1 receptor activity impairs serotonergic negative feedback. J Neurochem 2009, 109:935-944.
3. Baliki M.N., Chialvo D.R., Geha P.Y., Levy R.M., Harden R.N., Parrish T.B., et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 2006, 26:12165-12173.
4. Bartolomucci A., Carola V., Pascucci T., Puglisi-Allegra S., Cabib S., Lesch K.P., et al. Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice. Dis Model Mech 2010, 3:459-470.
5. Beltramo M., Stella N., Calignano A., Lin S.Y., Makriyannis A., Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 1997, 277:1094-1097.
6. Bertolini A., Ferrari A., Ottani A., Guerzoni S., Tacchi R., Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev 2006, 12:250-275.
7. Boylan C.B., Blue M.E., Hohmann C.F. Modeling early cortical serotonergic deficits in autism. Behav Brain Res 2007, 176:94-108.
8. Campanero M.A., Calahorra B., García-Quétglas E., López-Ocáriz A., Honorato J. Rapid liquid chromatographic assay for the determination of acetaminophen in plasma after propacetamol administration: application to pharmacokinetic studies. J Pharm Biomed Anal 1999, 20:327-334.
9. Cassano T., Gaetani S., Macheda T., Laconca L., Romano A., Morgese M.G., et al. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology 2011, 214:465-476.
10. Chakrabarti B., Kent L., Suckling J., Bullmore E., Baron-Cohen S. Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces. Eur J Neurosci 2006, 23:1944-1948.
11. 2 receptor. Neuroreport 2003, 14:743-747.
12. Chibnall J.T., Tait R.C., Harman B., Luebbert R.A. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia. J Am Geriatr Soc 2005, 53:1921-1929.
13. 1 receptors by the antagonist/inverse agonist AM281. Synapse 2000, 38:477-482.
14. Courade J.P., Caussade F., Martin K., Besse D., Delchambre C., Hanoun N., et al. Effects of acetaminophen on monoaminergic systems in the rat central nervous system. Naunyn Schmiedebergs Arch Pharmacol 2001, 364:534-537.
15. Dani M., Guindon J., Lambert C., Beaulieu P. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur J Pharmacol 2007, 573:214-215.
16. Daya S., Anoopkumar-Dukie S. Acetaminophen inhibits liver trytophan-2,3-dioxygenase activity with a concomitant rise in brain serotonin levels and a reduction in urinary 5-hydroxyindole acetic acid. Life Sci 2000, 67:235-240.
17. Defensor E.B., Pearson B.L., Pobbe R.L., Bolivar V.J., Blanchard D.C., Blanchard R.J. A novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf/J mice. Behav Brain Res 2011, 217:302-308.
18. Derntl B., Seidel E.M., Eickhoff S.B., Kellermann T., Gur R.C., Schneider F., et al. Neural correlates of social approach and withdrawal in patients with major depression. Soc Neurosci 2011, 6:482-501.
19. Dewall C.N., Macdonald G., Webster G.D., Masten C.L., Baumeister R.F., Powell C., et al. Acetaminophen reduces social pain: behavioral and neural evidence. Psychol Sci 2010, 21:931-937.
20. Eisenberger N.I., Lieberman M.D., Williams K.D. Does rejection hurt? An FMRI study of social exclusion. Science 2003, 302:290-292.
21. Eisenberger N.I., Jarcho J.M., Lieberman M.D., Naliboff B.D. An experimental study of shared sensitivity to physical pain and social rejection. Pain 2006, 126:132-138.
22. Feldman R., Vengrober A. Posttraumatic stress disorder in infants and young children exposed to war-related trauma. J Am Acad Child Adolesc Psychiatry 2011, 50:645-658.
23. File S.E., Seth P. A review of 25 years of the social interaction test. Eur J Pharmacol 2003, 463:35-53.
24. Filipenko M.L., Beilina A.G., Alekseyenko O.V., Dolgov V.V., Kudryavtseva N.N. Increase in expression of brain serotonin transporter and monoamine oxidase a genes induced by repeated experience of social defeats in male mice. Biochemistry 2002, 67:451-455.
25. Gerretsen P., Graff-Guerrero A., Menon M., Pollock B.G., Kapur S., Vasdev N., et al. Is desire for social relationships mediated by the serotonergic system in the prefrontal cortex? An [(18)F]setoperone PET study. Soc Neurosci 2010, 5:375-383.
26. Gifford A.N., Bruneus M., Gatley S.J., Lan R., Makriyannis A., Volkow N.D. Large receptor reserve for cannabinoid actions in the central nervous system. J Pharmacol Exp Ther 1999, 288:478-483.
27. 1 receptor-mediated neurotransmission decreases marble burying behavior in mice. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:434-438.
28. 2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. J Neurochem 2011, 116:291-303.
29. 1 receptors. J Pharmacol Exp Ther 2009, 331:186-196.
30. 1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci 2004, 19:1906-1912.
31. Hardison S., Weintraub S.T., Giuffrida A. Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations. Prostaglandins Other Lipid Mediat 2006, 81:106-112.
32. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991, 11:563-583.
33. Högestätt E.D., Jönsson B.A., Ermund A., Andersson D.A., Björk H., Alexander J.P., et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem 2005, 280:31405-31412.
34. Hoyle D., Juhasz G., Aso E., Chase D., del Rio J., Fabre V., et al. Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression. Eur Neuropsychopharmacol 2011, 21:3-10.
35. 1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 1995, 68:65-70.
36. Lafourcade M., Elezgarai I., Mato S., Bakiri Y., Grandes P., Manzoni O.J. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One 2007, 2:e709.
37. 1 receptor is expressed on serotonergic and dopaminergic neurons. Eur J Pharmacol 2008, 578:137-141.
38. Lazary J., Lazary A., Gonda X., Benko A., Molnar E., Hunyady L., et al. Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:1118-1127.
39. Mallet C., Daulhac L., Bonnefont J., Ledent C., Etienne M., Chapuy E., et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 2008, 139:190-200.
40. Mallet C., Barrière D.A., Ermund A., Jönsson B.A., Eschalier A., Zygmunt P.M., et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One 2010, 5:e12748.
41. Moy S.S., Nadler J.J., Young N.B., Perez A., Holloway L.P., Barbaro R.P., et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007, 176:4-20.
42. 1 receptors. Naunyn Schmiedebergs Arch Pharmacol 2000, 361:19-24.
43. Newberg A.B., Hersh E.V., Levin L.M., Giannakopoulos H., Secreto S.A., Wintering N.A., et al. Double-blind, placebo-controlled, randomized pilot study of cerebral blood flow patterns employing SPECT imaging in dental postsurgical pain patients with and without pain relief. Clin Ther 2011, 33:1894-1903.
44. O'Connor J.C., André C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 2009, 29:4200-4209.
45. Onaivi E.S., Ishiguro H., Gu S., Liu Q.R. CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol 2012, 26:92-103.
46. 1 receptors. Eur J Pharmacol 2006, 531:280-281.
47. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 2006, 318:304-311.
48. Pickering G., Loriot M.A., Libert F., Eschalier A., Beaune P., Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006, 79:371-378.
49. Pini L.A., Sandrini M., Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 1996, 308:31-40.
50. Pinkham A.E., Hopfinger J.B., Pelphrey K.A., Piven J., Penn D.L. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res 2008, 99:164-175.
51. Ruggieri V., Vitale G., Pini L.A., Sandrini M. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:219-229.
52. Rutkowska M., Jamontt J., Gliniak H. Effects of cannabinoids on the anxiety-like response in mice. Pharmacol Rep 2006, 58:200-206.
53. Sandrini M., Vitale G., Ruggieri V., Pini L.A. Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. Inflamm Res 2007, 56:139-142.
54. Schultz S.T. Can autism be triggered by acetaminophen activation of the endocannabinoid system?. Acta Neurobiol Exp 2010, 70:227-231.
55. Seillier A., Advani T., Cassano T., Hensler J.G., Giuffrida A. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Int J Neuropsychopharmacol 2010, 3:373-386.
56. 1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 2001, 77:1048-1057.
57. Sinning C., Watzer B., Coste O., Nüsing R.M., Ott I., Ligresti A., et al. New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide. J Med Chem 2008, 51:7800-7805.
58. Spencer C.M., Alekseyenko O., Hamilton S.M., Thomas A.M., Serysheva E., Yuva-Paylor L.A., et al. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res 2011, 4:40-56.
59. Thomas A., Burant A., Bui N., Graham D., Yuva-Paylor L.A., Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) 2009, 204:361-373.
60. Trezza V., Vanderschuren L.J. Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology (Berl) 2008, 197:217-227.
61. Trezza V., Cuomo V., Vanderschuren L.J. Cannabis and the developing brain: insights from behavior. Eur J Pharmacol 2008, 585:441-452.
62. Umathe S.N., Manna S.S., Utturwar K.S., Jain N.S. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1191-1199.
63. Wang L.H., Rudolph A.M., Benet L.Z. Distribution and fate of acetaminophen conjugates in fetal lambs in utero. J Pharmacol Exp Ther 1985, 235:302-307.
64. Wiley J.L., Smith F.L., Razdan R.K., Dewey W.L. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. Eur J Pharmacol 2005, 510:59-68.
65. Zhang P.W., Ishiguro H., Ohtsuki T., Hess J., Carillo F., Walther D., et al. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with poly substance abuse. Mol Psychiatry 2004, 9:916-931.